{"id":111193,"date":"2020-07-21T09:50:45","date_gmt":"2020-07-21T13:50:45","guid":{"rendered":"https:\/\/www.ucf.edu\/news\/?p=111193"},"modified":"2025-06-17T16:27:50","modified_gmt":"2025-06-17T20:27:50","slug":"cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant","status":"publish","type":"post","link":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/","title":{"rendered":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant"},"content":{"rendered":"

One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer treatments.<\/p>\n

In May, \u00a0a cell-based cancer immunotherapy that utilizes a nanoparticle developed at Â鶹ӳ»­´«Ã½ to stimulate a patient\u2019s natural cancer-killing cells, headed to Phase II clinical trial.<\/a><\/p>\n

College of Medicine<\/a> Associate Professor Alicja Copik and her team developed the technique in 2016 and then co-founded the company CytoSen to take the concept to market. In 2019, the company was acquired by Netherlands-based bio-pharmaceutical firm Kiadis Pharma<\/a>, which saw the potential to develop new treatment options for cancer patients.<\/p>\n

Last week, Kiadis licensed a bundle of technologies \u2013 including the one developed at Â鶹ӳ»­´«Ã½ \u2013 to Sanofi in a deal estimated about $1 billion. If the technologies advance through clinical trials and are approved, royalties would follow from commercial sales of products on the market.<\/p>\n

Sanofi is based in France and employees more than 100,000 people in 100 countries. The company has 91 products in clinical trials. In 2019, it was ranked the eighth largest pharma company in the world based on sales of about $27.7 billion.<\/p>\n

\u201cThe licensing of Kiadis\u2019 CD38KO K-NK cells is particularly exciting for Sanofi since we will be studying this cell-based therapeutic with our recently FDA-approved treatment for patients with difficult-to-treat multiple myeloma, in hopes of bringing even more options to these patients with this hematologic cancer,\u201d John Reed, the global head of research for Sanofi, says in a press release. \u201cAt Sanofi, we are committed to pioneering treatments that address unmet healthcare challenges<\/a>. Innovative collaborations, such as this partnership with Kiadis, have the potential to expand the clinical benefits of our medicines by combining them with synergistic partnered therapeutics to deliver improved outcomes for patients.\u201d<\/p>\n

Natural killer (NK) cells are part of the body\u2019s defense system and act as an army to protect us from invaders such as viruses and infections. Copik discovered a way to make NK cells even more powerful \u2013 by stimulating them with nanoparticles that multiply them and heighten their killing ability \u2013 and then use the cells to fight cancer. \u201cThat\u2019s what it is all about,\u201d she says, \u201cgiving patients a fighting chance of cancer survival.\u201d<\/p>\n

Copik\u2019s story about natural cancer-killing cells illustrates one of the paths university research<\/a> can take to the marketplace where it can change lives. This is why universities invest in Technology Transfer Offices<\/a> that help innovations get patented and licensed to industry. The commercialization process can take years.<\/p>\n

\u201cOur office is grateful to have the unique opportunity to partner with industry to bring the most promising technological advances developed by our dedicated researchers to market to impact global healthcare and improve quality of life,\u201d says Svetlana Shtrom, Â鶹ӳ»­´«Ã½\u2019s director of Office of Technology Transfer.<\/p>\n","protected":false},"excerpt":{"rendered":"

College of Medicine Associate Professor Alicja Copik\u2019s nanoparticle technology that helps stimulate natural cancer-killing cells is now in the hands of Sanofi, which hopes to find new blood-cancer treatments.<\/p>\n","protected":false},"author":16,"featured_media":111195,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"lazy_load_responsive_images_disabled":false,"footnotes":"","_links_to":"","_links_to_target":"","_wp_rev_ctl_limit":""},"categories":[5,23,24],"tags":[15972,979,3488,20720],"tu_author":[],"class_list":["post-111193","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-colleges","category-research","category-science-technology","tag-alicja-copik","tag-college-of-medicine","tag-office-of-technology-transfer","tag-technology-transfer-office"],"yoast_head":"\nCancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant | Â鶹ӳ»­´«Ã½ News<\/title>\n<meta name=\"description\" content=\"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant\" \/>\n<meta property=\"og:description\" content=\"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/\" \/>\n<meta property=\"og:site_name\" content=\"Â鶹ӳ»­´«Ã½ News | Â鶹ӳ»­´«Ã½ Today\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Â鶹ӳ»­´«Ã½\" \/>\n<meta property=\"article:published_time\" content=\"2020-07-21T13:50:45+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-17T20:27:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Zenaida Kotala\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Â鶹ӳ»­´«Ã½\" \/>\n<meta name=\"twitter:site\" content=\"@Â鶹ӳ»­´«Ã½\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Zenaida Kotala\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/\"},\"author\":{\"name\":\"Zenaida Kotala\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/4f0fdedfa744a8bfddd06132e6ce9b5e\"},\"headline\":\"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant\",\"datePublished\":\"2020-07-21T13:50:45+00:00\",\"dateModified\":\"2025-06-17T20:27:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/\"},\"wordCount\":469,\"image\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2020\\\/07\\\/WEBCopiknewphoto.jpg\",\"keywords\":[\"Alicja Copik\",\"College of Medicine\",\"Office of Technology Transfer\",\"Technology Transfer Office\"],\"articleSection\":[\"Colleges & Campus\",\"Research\",\"Science & Technology\"],\"inLanguage\":\"en-US\",\"copyrightYear\":\"2020\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/\",\"name\":\"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant | Â鶹ӳ»­´«Ã½ News\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2020\\\/07\\\/WEBCopiknewphoto.jpg\",\"datePublished\":\"2020-07-21T13:50:45+00:00\",\"dateModified\":\"2025-06-17T20:27:50+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/4f0fdedfa744a8bfddd06132e6ce9b5e\"},\"description\":\"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2020\\\/07\\\/WEBCopiknewphoto.jpg\",\"contentUrl\":\"https:\\\/\\\/www.ucf.edu\\\/wp-content\\\/blogs.dir\\\/20\\\/files\\\/2020\\\/07\\\/WEBCopiknewphoto.jpg\",\"width\":1200,\"height\":800,\"caption\":\"Alicja Copik\u2019s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/\",\"name\":\"Â鶹ӳ»­´«Ã½ News | Â鶹ӳ»­´«Ã½ Today\",\"description\":\"Central Florida Research, Arts, Technology, Student Life and College News, Stories and More\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/#\\\/schema\\\/person\\\/4f0fdedfa744a8bfddd06132e6ce9b5e\",\"name\":\"Zenaida Kotala\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g\",\"caption\":\"Zenaida Kotala\"},\"url\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/author\\\/zkotala\\\/\"},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.ucf.edu\\\/news\\\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\\\/#local-main-organization-logo\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Â鶹ӳ»­´«Ã½\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant | Â鶹ӳ»­´«Ã½ News","description":"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/","og_locale":"en_US","og_type":"article","og_title":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant","og_description":"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer","og_url":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/","og_site_name":"Â鶹ӳ»­´«Ã½ News | Â鶹ӳ»­´«Ã½ Today","article_publisher":"https:\/\/www.facebook.com\/Â鶹ӳ»­´«Ã½","article_published_time":"2020-07-21T13:50:45+00:00","article_modified_time":"2025-06-17T20:27:50+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg","type":"image\/jpeg"}],"author":"Zenaida Kotala","twitter_card":"summary_large_image","twitter_creator":"@Â鶹ӳ»­´«Ã½","twitter_site":"@Â鶹ӳ»­´«Ã½","twitter_misc":{"Written by":"Zenaida Kotala","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#article","isPartOf":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/"},"author":{"name":"Zenaida Kotala","@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/4f0fdedfa744a8bfddd06132e6ce9b5e"},"headline":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant","datePublished":"2020-07-21T13:50:45+00:00","dateModified":"2025-06-17T20:27:50+00:00","mainEntityOfPage":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/"},"wordCount":469,"image":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg","keywords":["Alicja Copik","College of Medicine","Office of Technology Transfer","Technology Transfer Office"],"articleSection":["Colleges & Campus","Research","Science & Technology"],"inLanguage":"en-US","copyrightYear":"2020","copyrightHolder":{"@id":"https:\/\/www.ucf.edu\/#organization"}},{"@type":"WebPage","@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/","url":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/","name":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant | Â鶹ӳ»­´«Ã½ News","isPartOf":{"@id":"https:\/\/www.ucf.edu\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#primaryimage"},"image":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#primaryimage"},"thumbnailUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg","datePublished":"2020-07-21T13:50:45+00:00","dateModified":"2025-06-17T20:27:50+00:00","author":{"@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/4f0fdedfa744a8bfddd06132e6ce9b5e"},"description":"One of the biggest pharma companies in the world will use a nanoparticle technology developed at Â鶹ӳ»­´«Ã½ in hopes of coming up with new blood cancer","breadcrumb":{"@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#primaryimage","url":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg","contentUrl":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto.jpg","width":1200,"height":800,"caption":"Alicja Copik\u2019s story about natural cancer-killing cells illustrates one of the paths university research can take to the marketplace where it can change lives."},{"@type":"BreadcrumbList","@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ucf.edu\/news\/"},{"@type":"ListItem","position":2,"name":"Cancer-fighting Technology Developed at Â鶹ӳ»­´«Ã½ Licensed to French Pharmaceutical Giant"}]},{"@type":"WebSite","@id":"https:\/\/www.ucf.edu\/news\/#website","url":"https:\/\/www.ucf.edu\/news\/","name":"Â鶹ӳ»­´«Ã½ News | Â鶹ӳ»­´«Ã½ Today","description":"Central Florida Research, Arts, Technology, Student Life and College News, Stories and More","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ucf.edu\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.ucf.edu\/news\/#\/schema\/person\/4f0fdedfa744a8bfddd06132e6ce9b5e","name":"Zenaida Kotala","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b942e6b48d92cfeb8c940ffaf4efc2f77419a530cc2bd85f06c36bbffea9b02a?s=96&d=mm&r=g","caption":"Zenaida Kotala"},"url":"https:\/\/www.ucf.edu\/news\/author\/zkotala\/"},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ucf.edu\/news\/cancer-fighting-technology-developed-at-ucf-licensed-to-french-pharmaceutical-giant\/#local-main-organization-logo","url":"","contentUrl":"","caption":"Â鶹ӳ»­´«Ã½"}]}},"thumbnail":"https:\/\/www.ucf.edu\/wp-content\/blogs.dir\/20\/files\/2020\/07\/WEBCopiknewphoto-300x200.jpg","primary_category":5,"primary_tag":979,"author_byline":"Zenaida Gonzalez Kotala","acf":[],"_links":{"self":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/111193","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/comments?post=111193"}],"version-history":[{"count":7,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/111193\/revisions"}],"predecessor-version":[{"id":147727,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/posts\/111193\/revisions\/147727"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/media\/111195"}],"wp:attachment":[{"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/media?parent=111193"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/categories?post=111193"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/tags?post=111193"},{"taxonomy":"tu_author","embeddable":true,"href":"https:\/\/www.ucf.edu\/news\/wp-json\/wp\/v2\/tu_author?post=111193"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}